Integrated analysis of microRNA-target interactions with clinical outcomes for cancers

BMC Med Genomics. 2014;7 Suppl 1(Suppl 1):S10. doi: 10.1186/1755-8794-7-S1-S10. Epub 2014 May 8.


Background: Clinical statement alone is not enough to predict the progression of disease. Instead, the gene expression profiles have been widely used to forecast clinical outcomes. Many genes related to survival have been identified, and recently miRNA expression signatures predicting patient survival have been also investigated for several cancers. However, miRNAs and their target genes associated with clinical outcomes have remained largely unexplored.

Methods: Here, we demonstrate a survival analysis based on the regulatory relationships of miRNAs and their target genes. The patient survivals for the two major cancers, ovarian cancer and glioblastoma multiforme (GBM), are investigated through the integrated analysis of miRNA-mRNA interaction pairs.

Results: We found that there is a larger survival difference between two patient groups with an inversely correlated expression profile of miRNA and mRNA. It supports the idea that signatures of miRNAs and their targets related to cancer progression can be detected via this approach.

Conclusions: This integrated analysis can help to discover coordinated expression signatures of miRNAs and their target mRNAs that can be employed for therapeutics in human cancers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Computational Biology / methods*
  • Female
  • Glioblastoma / diagnosis*
  • Glioblastoma / genetics*
  • Glioblastoma / therapy
  • Humans
  • MicroRNAs / genetics*
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / therapy
  • Prognosis
  • Survival Analysis
  • Transcriptome


  • MicroRNAs